Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jack Parnell"'
Publikováno v:
Echo Research and Practice, Vol 6, Iss 2, Pp I1-I2 (2019)
Externí odkaz:
https://doaj.org/article/b1c3d6a9b9c7478f970801a862a355e8
Autor:
Andrew J. Steele, Jan A. Burger, Greg P. Coffey, Francesco Forconi, Graham Packham, Freda K. Stevenson, Jonathan C. Strefford, Anjali Pandey, Pamela B. Conley, Peter W.M. Johnson, Andrew Davies, Lindsay D. Smith, Jack Parnell, Alice Hayman, Sarah Wilmore, Marta Larrayoz, Rachel C. Dobson, Stefan Koehrer, Matthew D. Blunt
Supplementary methods and Figures Supplementary Figure 1. Effect of cerdulatinib on Immobilised anti-IgM mediated signaling Supplementary Figure 2. Effect of cerdulatinib on soluble anti-IgM mediated signaling Supplementary Figure 3. Effect of cerdul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a468e825532cc2770eba48a39c5394f7
https://doi.org/10.1158/1078-0432.22463541
https://doi.org/10.1158/1078-0432.22463541
Autor:
Andrew J. Steele, Jan A. Burger, Greg P. Coffey, Francesco Forconi, Graham Packham, Freda K. Stevenson, Jonathan C. Strefford, Anjali Pandey, Pamela B. Conley, Peter W.M. Johnson, Andrew Davies, Lindsay D. Smith, Jack Parnell, Alice Hayman, Sarah Wilmore, Marta Larrayoz, Rachel C. Dobson, Stefan Koehrer, Matthew D. Blunt
Purpose: B-cell receptor (BCR)–associated kinase inhibitors, such as ibrutinib, have revolutionized the treatment of chronic lymphocytic leukemia (CLL). However, these agents are not curative, and resistance is already emerging in a proportion of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65982893f3a24771c803dc31b3ed3e60
https://doi.org/10.1158/1078-0432.c.6525432
https://doi.org/10.1158/1078-0432.c.6525432
Publikováno v:
Echo Research and Practice, Vol 6, Iss 2, Pp I1-I2 (2019)
Echo Research and Practice
Echo Research and Practice
Summary A 62-year-old man admitted with palpitations had a 12-lead ECG that revealed atrial flutter with 2:1 AV block (rate 150 bpm). Transthoracic echocardiography (TTE) revealed normal left ventricular size with impaired systolic function and sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d99058f2ff974cea750dab526c924c
https://erp.bioscientifica.com/view/journals/echo/6/2/ERP-19-0007.xml
https://erp.bioscientifica.com/view/journals/echo/6/2/ERP-19-0007.xml
Autor:
Anjali Pandey, Stefan Koehrer, Jonathan C. Strefford, Andrew J. Steele, Matthew D. Blunt, Alice Hayman, Andrew Davies, Greg Coffey, Freda K. Stevenson, Francesco Forconi, Pamela B. Conley, Sarah Wilmore, Jack Parnell, Lindsay D. Smith, Peter Johnson, Jan A. Burger, Marta Larrayoz, Rachel Dobson, Graham Packham
Purpose: B-cell receptor (BCR)–associated kinase inhibitors, such as ibrutinib, have revolutionized the treatment of chronic lymphocytic leukemia (CLL). However, these agents are not curative, and resistance is already emerging in a proportion of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55792179012f48052b8105e899855173
https://eprints.soton.ac.uk/401087/
https://eprints.soton.ac.uk/401087/
Autor:
Greg Coffey, Andrew J. Steele, Rachel Dobson, Matthew D. Blunt, Jack Parnell, Lindsay D. Smith, Peter Johnson, Graham Packham, Jonathan C. Strefford, Freda K. Stevenson, Marta Larrayoz, Andrew Davies, Mark S. Cragg, Francesco Forconi
Publikováno v:
Blood. 126:1716-1716
The emergence of B cell receptor (BCR) kinase inhibitors has proved effective for the treatment of a number of B-cell malignancies including chronic lymphocytic leukemia (CLL). BTK and PI3K inhibitors have clear efficacy in suppressing tumor progress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb960393d08bdbb3ddd18c7c36171bb1
https://doi.org/10.1182/blood.v126.23.1716.1716
https://doi.org/10.1182/blood.v126.23.1716.1716